Leo J. Redmond
Director/Miembro de la Junta en Presidio Pharmaceuticals, Inc. .
Perfil
Leo J.
Redmond is currently the Director at Presidio Pharmaceuticals, Inc. He previously worked as the Senior Director-Finance at Genentech, Inc. from 2000 to 2007.
He also served as the President & Chief Financial Officer at Pharco Pharmaceuticals, Inc. Additionally, Mr. Redmond held the position of Chief Financial Officer & Secretary at The Genentech Foundation from 2004 to 2007.
From 2019 to 2021, he was the Chief Financial & Accounting Officer at Allakos, Inc. Mr. Redmond obtained his undergraduate degree from the University of Kansas and holds an MBA from UCLA Anderson School of Management.
Cargos activos de Leo J. Redmond
Empresas | Cargo | Inicio |
---|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | 01/01/2011 |
Antiguos cargos conocidos de Leo J. Redmond.
Empresas | Cargo | Fin |
---|---|---|
ALLAKOS INC. | Director Financiero/CFO | 01/02/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Financiero/CFO | 01/12/2007 |
The Genentech Foundation | Director Financiero/CFO | 01/12/2007 |
PHARCO PHARMACEUTICALS | Director Financiero/CFO | - |
Formación de Leo J. Redmond.
University of Kansas | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALLAKOS INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Genentech Foundation | Miscellaneous |
Pharco Pharmaceuticals, Inc.
Pharco Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharco Pharmaceuticals, Inc. develops, manufactures, markets, distributes, and exports pharmaceutical products. It offers generics and branded generic drugs under the name of Pharco. The company was founded by Hassan Abbas Helmy in 1983 and is headquartered in Alexandria, Egypt. | Health Technology |
- Bolsa de valores
- Insiders
- Leo J. Redmond